All Stories

  1. Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03
  2. In-Transit Metastasis From Squamous Cell Carcinoma
  3. Important prognostic significance of lymph node density in patients with node positive oral tongue cancer
  4. Prognostic Significance of Lymph Node Ratio in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck
  5. Cutaneous Carcinoma
  6. Re-irradiation for Recurrent Skin Cancer
  7. Management of Nodal Metastases
  8. Skin: Basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma
  9. Volumetric and dosimetric changes to salivary glands during radiotherapy for head and neck cancer
  10. High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: A literature review
  11. Management of squamous cell and basal cell carcinomas of the head and neck with perineural invasion
  12. Merkel cell carcinoma: A case of palliative upper limb amputation in a patient with refractory in-transit metastases
  13. Squamous Cell Carcinoma of the Lip in Australian Patients
  14. Non-melanoma Skin Cancer of the Head and Neck
  15. Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck
  16. Merkel Cell Carcinoma, Adnexal Carcinoma and Basal Cell Carcinoma
  17. Non-melanoma Skin Cancer: Primary Non-surgical Therapies and Prevention Strategies
  18. Radiotherapy alone in patients with Merkel cell carcinoma: The Westmead Hospital experience of 41 patients
  19. Comparison of the AJCC N staging system in mucosal and cutaneous squamous head and neck cancer
  20. Assessment of the new nodal classification for cutaneous squamous cell carcinoma and its effect on patient stratification
  21. Outcome of Patients with Microscopic and Macroscopic Metastatic Nodal Merkel Cell Carcinoma: An Australian Experience
  22. OP023
  23. Perioperative Management of High Risk Primary Cutaneous Squamous Cell Carcinoma: Role of Radiologic Imaging, Elective Lymph Node Dissection, Sentinel Lymph Node Biopsy, and Adjuvant Radiotherapy
  24. Quality of life assessment in patients treated for metastatic cutaneous squamous cell carcinoma of the head and neck
  25. Prognostic significance of disease‐free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases
  26. Early‐stage squamous cell carcinoma of the lip: The Australian experience and the benefits of radiotherapy in improving outcome in high‐risk patients after resection
  27. Merkel cell carcinoma: The prognostic implications of an occult primary in stage IIIB (nodal) disease
  28. Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: Analysis of prognostic factors
  29. Analysis and Comparison of the 7th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System for Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck
  30. Merkel cell carcinoma: An Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients
  31. Relevance of the primary lesion in the prognosis of metastatic cutaneous squamous cell carcinoma
  32. Sentinel lymph node biopsy in patients with Merkel cell carcinoma: An emerging role and the Westmead hospital experience
  33. Distant metastases from cutaneous squamous cell carcinoma—analysis of AJCC stage IV
  34. Cutaneous carcinoma
  35. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy
  36. Merkel cell carcinoma metastatic to the transverse colon: Disease free after six years - cure or just prolonged remission?
  37. Metastatic head and neck cutaneous squamous cell carcinoma: Defining a low‐risk patient
  38. The Role of Radiotherapy Alone in Patients With Merkel Cell Carcinoma: Reporting the Australian Experience of 43 Patients
  39. Patients with clinically node negative extremity Merkel cell carcinoma: The importance of identifying and treating patients with microscopic nodal metastases
  40. POINT OF VIEW: Strategies to successfully publish your first manuscript
  41. Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes
  42. N1S3: A revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases
  43. Factors Influencing Relapse-Free Survival in Merkel Cell Carcinoma of the Lower Limb—A Review of 60 Cases
  44. The impact of 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia
  45. Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: The Westmead Hospital experience and a review of the literature
  46. Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite
  47. Metastatic cutaneous squamous cell carcinoma of the head and neck
  48. Time to rethink TNM staging in cutaneous SCC
  49. METASTATIC CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE SCALP
  50. Merkel cell carcinoma: a review of management
  51. Radiation Therapy in Organ Transplant Recipients
  52. The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck
  53. Merkel cell carcinoma of the head and neck: Is adjuvant radiotherapy necessary?
  54. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes
  55. High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck
  56. Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): An overview on management
  57. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck
  58. High‐risk cutaneous squamous cell carcinoma of the head and neck
  59. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes
  60. Defining patients with high‐risk cutaneous squamous cell carcinoma
  61. Internet access, awareness and utilization of web‐based evidence: A survey of Australian, New Zealand and Singaporean radiation oncology registrars*
  62. Salvage with supracricoid partial laryngectomy after radiation failure
  63. Merkel Cell Carcinoma: Improved Outcome With the Addition of Adjuvant Therapy
  64. MERKEL CELL CARCINOMA: IMPROVED OUTCOME WITH ADJUVANT RADIOTHERAPY
  65. Surgery and Adjuvant Radiotherapy in Patients with Cutaneous Head and Neck Squamous Cell Carcinoma Metastatic to Lymph Nodes: Combined Treatment Should be Considered Best Practice
  66. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck
  67. Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients?
  68. Primary small cell undifferentiated (neuroendocrine) carcinoma of the maxillary sinus
  69. Role of adjuvant radiotherapy in recurrent earlobe keloids
  70. Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach
  71. Metastatic Merkel cell carcinoma to the soft tissues of the lower back
  72. Views of Australian and New Zealand radiation oncologists and registrars about evidence-based medicine and their access to Internet based sources of evidence
  73. ANTERIOR TONGUE CANCER: AGE IS NOT A PREDICTOR OF OUTCOME AND SHOULD NOT ALTER TREATMENT
  74. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): A better outcome with surgery and adjuvant radiotherapy
  75. Leptomeningeal carcinomatosis from squamous cell carcinoma of the supraglottic larynx
  76. Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome
  77. Squamous cell carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inadequate excision?
  78. Role of modern radiotherapy in treating skin cancer
  79. Extent of Parotid Disease Influences Outcome in Patients With Metastatic Cutaneous Squamous Cell Carcinoma
  80. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil
  81. Australian and New Zealand radiation oncology work practices in 2000
  82. Mycosis fungoides involving the oral cavity
  83. Radiotherapy for Lentigo Maligna
  84. Parotid lymph-node metastases from cutaneous squamous-cell carcinomas: Treatment outcome and prognostic factors following surgery and adjuvant radiotherapy
  85. Basal cell carcinoma of the lip treated with radiotherapy
  86. Merkel cell carcinoma and multiple cutaneous squamous cell carcinomas in a patient with pityriasis rubra pilaris
  87. Calcifying epithelial odontogenic (Pindborg) tumor with malignant transformation and metastatic spread
  88. Squamous cell carcinoma of the lip. Patterns of relapse and outcome: Reporting the Westmead Hospital experience, 1980-1997
  89. Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours
  90. Lip cancer: Important management issues
  91. Three-dimensional dose distribution of tangential breast irradiation: results of a multicentre phantom dosimetry study
  92. Perineural spread leading to orbital invasion from skin cancer
  93. Lung cancer in patients aged 50 years and younger: Clinical characteristics, treatment details and outcome
  94. Aggressive cutaneous malignancies following cardiothoracic transplantation
  95. Aggressive cutaneous malignancies following cardiothoracic transplantation
  96. Tongue cancer in younger patients
  97. Cutaneous metastases from adenocarcinoma of unknown primary
  98. Cardiac transplant-related cutaneous malignancies in an australian recipient: Immunosuppression, friend or foe?
  99. Aggressive skin cancers in a cardiac transplant recipient
  100. Aggressive skin cancers in a cardiac transplant recipient
  101. Erythema multiforme-like reaction associated with radiotherapy
  102. Treatment of cutaneous angiosarcomas of the head and neck